A new clinical trial aimed at addressing obstructive sleep apnea and related conditions is set to launch, offering fresh insights into structured interventions and physiotherapy for patients. Sponsored by Medipol University, this upcoming study introduces a novel intervention method called ApneaTheraPlay (ATP), designed to improve pre-sleep routines through targeted exercises and innovative rehabilitation approaches.
In this article
- What is the focus of the trial?
- What interventions are being tested?
- Why is this significant for clinical practice?
- Frequently Asked Questions
- Key takeaways
- Disclaimer
- Full details
What is the focus of the trial?
This clinical trial, scheduled to begin recruitment under the sponsorship of Medipol University, targets individuals suffering from obstructive sleep apnea and exercise addiction. The study explores solutions to improve sleep quality and address behavioral issues through structured pre-sleep exercise regimens and tailored therapeutic activities.
Obstructive sleep apnea, a prevalent health issue, interrupts respiratory patterns during sleep and impacts millions globally. This condition often demands specialized interventions to minimize risks and improve life quality.
What interventions are being tested?
The trial investigates two behavioral interventions:
- Structured Pre-Sleep Exercise: This regimen incorporates scientifically designed activities to optimize relaxation and prepare patients for restful sleep.
- ApneaTheraPlay (ATP): A groundbreaking therapeutic approach that merges physical activity with behavioral intervention, ATP focuses on holistic patient rehabilitation through innovative techniques.
Both interventions aim to address underlying contributors to sleep disruptions and restore healthier sleep patterns while simultaneously exploring how structured exercise may mitigate exercise addiction, a concern related to excessive physical activity that can exacerbate apnea.
Why is this significant for clinical practice?
The introduction of therapy-based solutions like ApneaTheraPlay signals progress for healthcare providers and researchers in refining approaches to treat complex sleep disorders. By augmenting traditional intervention methods with novel structured exercise routines, the study opens doors to adaptive frameworks centered on tailored patient care and rehabilitation.
Healthcare professionals specializing in sleep medicine, physiotherapy, and rehabilitation will benefit from insights generated through this research, which may influence guidelines and protocols for treating sleep apnea and comorbid conditions.
Frequently Asked Questions
1. Who sponsors this clinical trial?
Medipol University is the sponsor behind this investigation.
2. What is the current status of recruitment?
The trial is noted as not yet recruiting, suggesting it will begin patient enrollment in the near future.
3. How can I access more details about the trial?
Further information is available on the ClinicalTrials.gov website.
Key takeaways
The upcoming trial investigating ApneaTheraPlay and related interventions represents an exciting development in sleep disorder management. By examining structured pre-sleep exercise alongside behavioral-driven treatments, the research aims to offer sustainable methods to optimize patients’ sleep quality and overall health outcomes.
Disclaimer
This article is informational and intended for professionals in clinical and regulatory fields. It does not constitute legal or medical advice. For specific guidance, consult regulatory documentation and healthcare guidelines.
For full information about the announcement, see the link below.
https://clinicaltrials.gov/study/NCT07214636?term=medical+device